Survival analysis of patients treated with ClIPd. (A) PFS, (B) DOR, (C) OS, and (D) PFS stratified by high-risk cytogenetics. High-risk cytogenetics were considered +1q (either gain or amplification), del(17p), t(4;14), or t(14;16). mo, months.